| Disruption of timing: NeuroHIV progression in the post-cART era KA McLaurin, H Li, RM Booze, CF Mactutus Scientific reports 9 (1), 827, 2019 | 53 | 2019 |
| Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders KA McLaurin, RM Booze, CF Mactutus Journal of neurovirology 24, 229-245, 2018 | 49 | 2018 |
| Synaptic connectivity in medium spiny neurons of the nucleus accumbens: A sex-dependent mechanism underlying apathy in the HIV-1 transgenic rat KA McLaurin, AK Cook, H Li, AF League, CF Mactutus, RM Booze Frontiers in Behavioral Neuroscience 12, 285, 2018 | 39 | 2018 |
| Progression of temporal processing deficits in the HIV-1 transgenic rat KA McLaurin, RM Booze, CF Mactutus Scientific reports 6 (1), 32831, 2016 | 31 | 2016 |
| HIV infection and neurocognitive disorders in the context of chronic drug abuse: evidence for divergent findings dependent upon prior drug history JM Illenberger, SB Harrod, CF Mactutus, KA McLaurin, A Kallianpur, ... Journal of Neuroimmune Pharmacology 15, 715-728, 2020 | 27 | 2020 |
| Sex matters: Robust sex differences in signal detection in the HIV-1 transgenic rat KA McLaurin, RM Booze, CF Mactutus, AJ Fairchild Frontiers in behavioral neuroscience 11, 212, 2017 | 27 | 2017 |
| HIV-associated apathy/depression and neurocognitive impairments reflect persistent dopamine deficits KA McLaurin, M Harris, V Madormo, SB Harrod, CF Mactutus, RM Booze Cells 10 (8), 2158, 2021 | 23 | 2021 |
| Diagnostic and prognostic biomarkers for HAND KA McLaurin, RM Booze, CF Mactutus Journal of neurovirology 25, 686-701, 2019 | 21 | 2019 |
| Unraveling individual differences in the HIV-1 transgenic rat: therapeutic efficacy of methylphenidate KA McLaurin, H Li, RM Booze, AJ Fairchild, CF Mactutus Scientific reports 8 (1), 136, 2018 | 21 | 2018 |
| Temporal processsing demands in the HIV-1 transgenic rat: amodal gating and implications for diagnostics KA McLaurin, RM Booze, CF Mactutus International Journal of Developmental Neuroscience 57, 12-20, 2017 | 20 | 2017 |
| A gap in time: extending our knowledge of temporal processing deficits in the HIV-1 transgenic rat KA McLaurin, LM Moran, H Li, RM Booze, CF Mactutus Journal of Neuroimmune Pharmacology 12, 171-179, 2017 | 20 | 2017 |
| Microglial HIV-1 expression: Role in HIV-1 associated neurocognitive disorders H Li, KA McLaurin, JM Illenberger, CF Mactutus, RM Booze Viruses 13 (5), 924, 2021 | 19 | 2021 |
| Selective estrogen receptor β agonists: A therapeutic approach for HIV-1 associated neurocognitive disorders KA McLaurin, LM Moran, RM Booze, CF Mactutus Journal of Neuroimmune Pharmacology 15, 264-279, 2020 | 16 | 2020 |
| Neurorestoration of sustained attention in a model of HIV-1 associated neurocognitive disorders LM Moran, KA McLaurin, RM Booze, CF Mactutus Frontiers in behavioral neuroscience 13, 169, 2019 | 15 | 2019 |
| Selective developmental alterations in the HIV-1 transgenic rat: opportunities for diagnosis of pediatric HIV-1 KA McLaurin, RM Booze, CF Mactutus Journal of neurovirology 23, 87-98, 2017 | 15 | 2017 |
| Posterior ventral tegmental area-nucleus accumbens shell circuitry modulates response to novelty H Li, JM Illenberger, MN Cranston, CF Mactutus, KA McLaurin, SB Harrod, ... PLoS One 14 (3), e0213088, 2019 | 14 | 2019 |
| S-Equol mitigates motivational deficits and dysregulation associated with HIV-1 KA McLaurin, SJ Bertrand, JM Illenberger, SB Harrod, CF Mactutus, ... Scientific Reports 11 (1), 11870, 2021 | 11 | 2021 |
| Ballistic labeling of pyramidal neurons in brain slices and in primary cell culture H Li, KA McLaurin, CF Mactutus, RM Booze JoVE (Journal of Visualized Experiments), e60989, 2020 | 11 | 2020 |
| A rat model of EcoHIV brain infection H Li, KA McLaurin, CF Mactutus, RM Booze JoVE (Journal of Visualized Experiments), e62137, 2021 | 10 | 2021 |
| S-Equol: A neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV KA McLaurin, H Li, AK Cook, RM Booze, CF Mactutus Journal of neurovirology 26, 704-718, 2020 | 9 | 2020 |
